New Alzheimer's Trial Data; Microbiome and MS; Monkeypox's Neuro Complications

(MedPage Today) -- The oral beta-amyloid blocker ALZ-801 (valiltramiprosate) reduced plasma phosphorylated tau (p-tau181) by 41% and preserved hippocampal volume in a phase II study of Alzheimer's patients with an APOE4 allele, Alzheon announced...